GALNT3 and hyperphosphatemia: In the mouse model developed by Ichikawa and colleagues [55], the ablation of GALNT3 in exons 2 and 3 led to decreased circulating intact Fgf23 levels with hyperphosphatemia, despite that high levels of Fgf23 were found in bone [55].